Serum cytokines MCP-1 and GCS-F as potential biomarkers in pediatric inflammatory bowel disease
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0288147 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Andrea Ott und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospital for General Pediatrics and Neonatology, Saarland University Medical Center, Homburg/Saar, Germany. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Inflammatory bowel diseases (IBDs) with the subtypes ulcerative colitis (UC) and Crohn disease (CD), are chronic autoimmune inflammatory disorders of the gastrointestinal tract. Cytokines are associated with the development and progression in pediatric IBD. We measured cytokine levels in pediatric IBD patients to assess their potential function as biomarkers in disease assessment.
Method
In this prospective cohort study, we enrolled 33 children with IBD. All patients were in stable remission for 3 months on enrollment. Patients who developed a relapse within six months after enrollment were classified as relapsers. Blood sampling was performed at enrolment and for relapsers in relapse and post-relapse. Serum concentrations of 14 cytokines, chemokines and growth factors (IL-1α, IL-1β, IL-6, IL-12p40, IP-10, TNF-α, IFN-γ, IL-10, IL-8, MIP-1α, MCP-1, MCP-3, G-CSF, GM-CSF) were measured simultaneously using multiplex bead-based sandwich immunoassay on Luminex 100 system.
Results
MCP-1 was significantly higher in CD patients compared to UC patients at each disease stage: stable remission (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hospital for General Pediatrics and Neonatology, Saarland University Medical Center, Homburg/Saar, Germany.
- Institute of Medical Biometry, Epidemiology and Medical Informatics, Saarland University, Homburg/Saar, Germany.
ORCID-Profile: Erol Tutdibi, Nasenien Nourkami-Tutdibi
Zitieren
APA
Ott, A., Tutdibi, E., Goedicke-Fritz, S., Schöpe, J., Zemlin, M., & Nourkami-Tutdibi, N. (2023). Serum cytokines MCP-1 and GCS-F as potential biomarkers in pediatric inflammatory bowel disease. PLOS ONE. https://doi.org/10.1371/journal.pone.0288147
Vancouver
Ott A, Tutdibi E, Goedicke-Fritz S, Schöpe J, Zemlin M, Nourkami-Tutdibi N. Serum cytokines MCP-1 and GCS-F as potential biomarkers in pediatric inflammatory bowel disease. PLOS ONE. 2023. doi:10.1371/journal.pone.0288147
BibTeX
@article{Ott2023,
author = {Ott, Andrea and Tutdibi, Erol and Goedicke-Fritz, Sybelle and Schöpe, Jakob and Zemlin, Michael and Nourkami-Tutdibi, Nasenien},
title = {Serum cytokines MCP-1 and GCS-F as potential biomarkers in pediatric inflammatory bowel disease},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0288147}
}
EUVIMED